Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for VanEck Biotech ETF (BBH : NSDQ)

• Company Description    The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $158.16 Daily Weekly Monthly 20 Day Moving Average: 8,980 shares Shares Outstanding: 3.10 (millions) Market Capitalization: $489.76 (millions) Beta: 0.84 52 Week High: $170.25 52 Week Low: $131.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.05% 1.09% 12 Week -1.31% -4.33% Year To Date -0.99% -4.63%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL - - -,- - - ph: - fax: - None None

• General Corporate Information    Officers - - - - - - - - - - - - - - - Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-INVEST FUND Sector: Finance CUSIP: 92189F726 SIC: 6726 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 3.10 Most Recent Split Date: 2.00 (3.00:1) Beta: 0.84 Market Capitalization: $489.76 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.47% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.75 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 12/19/2022 - $0.75 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 12/31/22 - - 09/30/22 - - 06/30/22 - - ROA 12/31/22 - - 09/30/22 - - 06/30/22 - - Current Ratio 12/31/22 - - 09/30/22 - - 06/30/22 - - Quick Ratio 12/31/22 - - 09/30/22 - - 06/30/22 - - Operating Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Net Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Pre-Tax Margin 12/31/22 - - 09/30/22 - - 06/30/22 - - Book Value 12/31/22 - - 09/30/22 - - 06/30/22 - - Inventory Turnover 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Equity 12/31/22 - - 09/30/22 - - 06/30/22 - - Debt-to-Capital 12/31/22 - - 09/30/22 - - 06/30/22 - -

Powered by Zacks Investment Research ©